CN Patent

CN121489917A — 用于皮下注射的氯胺酮制剂

Assigned to Beckson Biomedical Co · Expires 2026-02-10 · 0y expired

What this patent protects

本文提供了用于皮下注射的氯胺酮制剂，特别是可用于治疗多种疾病和障碍的氯胺酮的皮下制剂。本发明提供的皮下氯胺酮制剂减少了注射部位的刺激和疼痛。

USPTO Abstract

本文提供了用于皮下注射的氯胺酮制剂，特别是可用于治疗多种疾病和障碍的氯胺酮的皮下制剂。本发明提供的皮下氯胺酮制剂减少了注射部位的刺激和疼痛。

Drugs covered by this patent

esketamine-hydrochloride (ESKETAMINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN121489917A
Jurisdiction: CN
Classification: —
Expires: 2026-02-10
Drug substance claim: No
Drug product claim: No
Assignee: Beckson Biomedical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.